Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Ultrasound in Medicine & Biology|March 16, 2025
Two-dimensional Speckle Tracking Echocardiography and Fetal Cardiac Performance During Fetoscopic Repair of MyelomeningoceleStephanie A Eyerly-Webb, Cathleen R Pruitt, Trisha Gipple, et al.Medical Mycology|September 15, 2001
Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visitsB A Lasker, C M Elie, T J Lott, et al.Journal of Medicinal Chemistry|July 30, 1999
Design and synthesis of isoxazoline derivatives as factor Xa inhibitors. 1M L Quan, A Y Liauw, C D Ellis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 19, 1999
The epidemiology of candidemia in two United States cities: results of a population-based active surveillanceA S Kao, M E Brandt, W R Pruitt, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitorsJ V Duncia, J B Santella, C A Higley, et al.Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic coreJ M Fevig, D J Pinto, Q Han, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 1, 1996
Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by EchocardiographyH Rakowski, C Appleton, K L Chan, et al.Journal for Immunotherapy of Cancer|July 1, 2026
PARP inhibition combined with a T-cell receptor β chain-directed antibody fusion molecule drives polyclonal antitumor immunity and tumor regressionGinette Santiago-Sanchez, Francesca Rosato, Kellsye P Fabian, et al.Journal of Medicinal Chemistry|December 4, 2003
Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1)James R Pruitt, Donald J P Pinto, Robert A Galemmo, et al.Bioorganic & Medicinal Chemistry Letters|April 10, 2007
CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicityJames R Pruitt, Douglas G Batt, Dean A Wacker, et al.Pageof 6